Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov;26(6):1345-1358.
doi: 10.1007/s10741-020-09978-0.

The management of atrial fibrillation in heart failure: an expert panel consensus

Dimitrios Farmakis  1   2 , Christina Chrysohoou  3 , Gregory Giamouzis  4 , George Giannakoulas  5 , Michalis Hamilos  6 , Katerina Naka  7 , Stylianos Tzeis  8 , Sotirios Xydonas  9 , Apostolos Karavidas  10 , John Parissis  11
Affiliations
Review

The management of atrial fibrillation in heart failure: an expert panel consensus

Dimitrios Farmakis et al. Heart Fail Rev. 2021 Nov.

Abstract

Heart failure (HF) and atrial fibrillation (AF) often coexist, being closely interrelated as the one increases the prevalence and incidence and worsens the prognosis of the other. Their frequent coexistence raises several challenges, including under-diagnosis of HF with preserved ejection fraction in AF and of AF in HF, characterization and diagnosis of atrial cardiomyopathy, target and impact of rate control therapy on outcomes, optimal rhythm control strategy in the era of catheter ablation, HF-related thromboembolic risk and management of anticoagulation in patients with comorbidities, such as chronic kidney disease or transient renal function worsening, coronary artery disease or acute coronary syndromes, valvular or structural heart disease interventions and cancer. In the present document, derived by an expert panel meeting, we sought to focus on the above challenging issues, outlining the existing evidence and identifying gaps in knowledge that need to be addressed.

Keywords: Atrial fibrillation; Direct oral anticoagulants; Heart failure; Non-vitamin K antagonist oral anticoagulants; Rate control; Rhythm control.

PubMed Disclaimer

References

    1. Farmakis D, Stafylas P, Giamouzis G, Maniadakis N, Parissis J (2016) The medical and socioeconomic burden of heart failure: a comparative delineation with cancer. Int J Cardiol 203:279–281 - PubMed - DOI
    1. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJL (2014) Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 129:837–847 - PubMed - DOI
    1. Stafylas P, Farmakis D, Kourlaba G, Giamouzis G, Tsarouhas K, Maniadakis N, Parissis J (2017) The clinical and economic burden in Greece. Int J Cardiol 227:923–929 - PubMed - DOI
    1. Komajda M, Anker SD, Cowie MR, Filippatos GS, Mengelle B, Ponikowski P, Tavazzi L, QUALIFY Investigators (2016) Physicians’ adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey. Eur J Heart Fail 18:514–522 - PubMed - DOI
    1. Santhanakrishnan R, Wang N, Larson MG, Magnani JW, McManus DD, Lubitz SA, Ellinor PT, Cheng S, Vasan RS, Lee DS, Wang TJ, Levy D, Benjamin EJ, Ho JE (2016) Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation. 133:484–492 - PubMed - PMC - DOI

MeSH terms

LinkOut - more resources